Autopsy report · NCT02671084

Sevoflurane and Percutaneous Coronary Intervention by Stent

“interim analysis suggests futility”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 4 years 2 months before it stopped.
• 701 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 4

Sponsor

Instituto Dante Pazzanese de Cardiologia

Sponsor type

University, hospital or other

Conditions

Myocardial Infarction

Interventions

sevoflurane

Participants

701

Sites

1

Countries

Brazil

Trials that died the same way

• Bivalirudin Infusion for Ventricular Infarction Limitation
  “Futility at the interim analysis.” (94% match in meaning)
• Perioperative Treprostinil in Pediatric Patients Undergoing the Fontan Operation
  “Interim futility analysis” (88% match in meaning)
• Study of M5049 in DM and PM Participants (NEPTUNIA)
  “Based on interim analyses for futility” (87% match in meaning)
• Efficacy and Safety Study of DP-b99 in Treating Acute Ischemic Stroke
  “The result of a pre-planned interim futility analysis” (87% match in meaning)
• Interest of Intravitreal Injections of Anti-VEGF as Initial and Adjuvant Treatment in Coats Disease
  “Study futility based on the interim analysis” (82% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.